Having recently embarked on my own commentary of the Pharmaceutical industry, I was intrigued to read a recent article listing 6 ways Pharma may use social media.
The article itself provides some great points around topics such as education, clinical trial recruitment, listening etc, but my questions are raised from an end of article warning to carefully review guidance from the FDA.
With so much digital content created on a daily basis by thousands of companies, I'm interested to learn how thorough regulator checks and surveillance can manage/audit this daily expanding market?
Although social media is nearly ubiquitous at this point, pharmaceutical firms still struggle to varying degrees with how to use social media while complying with rules and regulations that govern communications with the public, consumer and patient. However, according to Dr. Kevin Campbell MD, FACC, social media is an ideal channel for pharmaceutical and device firms to educate, market, listen and connect with customers, patients and physicians .